Regentatlantic Capital LLC Medtronic PLC Transaction History

Regentatlantic Capital LLC

$3.34 Billion
Q3 2022

A detailed history of Regentatlantic Capital LLC transactions in Medtronic PLC stock. As of the latest transaction made, Regentatlantic Capital LLC holds 43,740 shares of MDT stock, worth $3.54 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

43,740

Previous 49,383 11.43%

Holding current value

$3.54 Million

Previous $4.43 Million 20.31%

% of portfolio

0.11%

Previous 0.15%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$80.75 - $95.31 $455,672 - $537,834	-5,643 Reduced 11.43%	43,740 $3.53 Million
Q2 2022 Aug 15, 2022	SELL	$87.4 - $113.09 $475,368 - $615,096	-5,439 Reduced 9.92%	49,383 $4.43 Million
Q1 2022 May 02, 2022	SELL	$100.58 - $112.38 $174,606 - $195,091	-1,736 Reduced 3.07%	54,822 $6.08 Million
Q4 2021 Jan 27, 2022	SELL	$99.53 - $127.75 $868,100 - $1.11 Million	-8,722 Reduced 13.36%	56,558 $5.85 Million
Q3 2021 Nov 15, 2021	BUY	$122.75 - $135.17 $57,938 - $63,800	472 Added 0.73%	65,280 $8.18 Million
Q2 2021 Aug 12, 2021	SELL	$118.19 - $131.5 $49,285 - $54,835	-417 Reduced 0.64%	64,808 $8.05 Million
Q1 2021 Apr 29, 2021	SELL	$111.18 - $119.74 $96,504 - $103,934	-868 Reduced 1.31%	65,225 $7.71 Million
Q4 2020 Feb 04, 2021	BUY	$100.57 - $117.14 $339,624 - $395,581	3,377 Added 5.38%	66,093 $7.74 Million
Q3 2020 Oct 13, 2020	BUY	$90.13 - $108.78 $41,009 - $49,494	455 Added 0.73%	62,716 $6.52 Million
Q2 2020 Aug 13, 2020	BUY	$84.11 - $103.33 $31,036 - $38,128	369 Added 0.6%	62,261 $5.71 Million
Q1 2020 May 14, 2020	SELL	$72.92 - $121.3 $96,254 - $160,116	-1,320 Reduced 2.09%	61,892 $5.58 Million
Q4 2019 Feb 04, 2020	SELL	$104.49 - $114.54 $57,051 - $62,538	-546 Reduced 0.86%	63,212 $7.17 Million
Q3 2019 Oct 22, 2019	BUY	$98.02 - $111.18 $177,416 - $201,235	1,810 Added 2.92%	63,758 $6.93 Million
Q2 2019 Jul 23, 2019	BUY	$84.15 - $99.38 $2.05 Million - $2.42 Million	24,324 Added 64.65%	61,948 $6.03 Million
Q1 2019 May 03, 2019	BUY	$82.45 - $93.79 $845,359 - $961,628	10,253 Added 37.46%	37,624 $3.43 Million
Q4 2018 Jan 30, 2019	BUY	$85.8 - $99.49 $296,953 - $344,334	3,461 Added 14.48%	27,371 $2.49 Million
Q3 2018 Oct 30, 2018	SELL	$85.91 - $99.17 $21,477 - $24,792	-250 Reduced 1.03%	23,910 $2.35 Million
Q2 2018 Jul 31, 2018	BUY	$77.48 - $87.83 $269,010 - $304,945	3,472 Added 16.78%	24,160 $2.07 Million
Q1 2018 Apr 23, 2018	BUY	$76.55 - $87.26 $397,294 - $452,879	5,190 Added 33.49%	20,688 $1.66 Million
Q4 2017 Jan 23, 2018	BUY	$76.93 - $83.5 $356,955 - $387,440	4,640 Added 42.73%	15,498 $1.25 Million
Q3 2017 Oct 25, 2017	BUY	$77.71 - $84.6 $843,775 - $918,586	10,858	10,858 $844,000

Others Institutions Holding MDT

# of Institutions

2,288

Shares Held

1.02B

Call Options Held

8.05M

Put Options Held

7.19M

View Full List

About Medtronic plc

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $108B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

More about MDT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Regentatlantic Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regentatlantic Capital LLC with notifications on news.

Account

Regentatlantic Capital LLC Medtronic PLC Transaction History